Research Article

Application of Molecular Modeling to Urokinase Inhibitors Development

Table 8

Structures, docking, and postprocessing score results, MOPAC enthalpies and experimental uPA inhibition activity (IC50) of synthesized compounds. N.b.: non binder.

NumberIDStructureSOL score, kcal/molDISCORE score, kcal/molMOPAC score, kcal/molExperiment, M

1U002R625176.tab.008a−4.73−3.32−47.12n.b.
2U001R625176.tab.008b−4.62−4.39−48.29n.b.
3U007R625176.tab.008c−4.86−4.71−44.56n.b.
4U003P625176.tab.008d−4.59−3.99−49.51n.b.
5U005r625176.tab.008e−5.04−4.76−59.86500
6U006R625176.tab.008f−4.73−4.74−13.55n.b.
7U009T625176.tab.008g−7.14−7.22−44.09n.b.
8U012T625176.tab.008h−6.91−5.24−56.68n.b.
9U013T625176.tab.008i−7.62−5.08−37.91n.b.
10U014R625176.tab.008j−4.15−4.25−54.76200
11U014aR625176.tab.008k−4.57−4.14−49.69n.b.
12U015R625176.tab.008l−4.13−4.64−64.69n.b.
13U017R625176.tab.008m−4.15−4.45−60.80200
14U019R625176.tab.008n−4.21−4.08−53.54500
15U020R625176.tab.008o−4.02−3.21−49.54500
16U021R625176.tab.008p−4.74−5.50−61.59500
17U024R625176.tab.008q−5.10−5.51−59.9433
18U026R625176.tab.008r−5.56−5.85−61.614–20